

According to University of Queensland research, being overweight can reduce the body’s antibody response to SARS-CoV-2 infection but not immunization.
The discovery builds on the team’s previous research on COVID-19’s effects on overweight persons, according to research lead Marcus Tong of the School of Chemistry and Molecular Biosciences. The study appears in Clinical & Translational Immunology.
“We’ve previously shown that being overweight—not just being obese—increases the severity of SARS-CoV-2,” Mr. Tong.
“But this work shows that being overweight creates an impaired antibody response to SARS-CoV-2 infection but not to vaccination.”
At three to 13 months post-infection, the research team collected blood samples from COVID-19-free participants.
“At three months post-infection, an elevated BMI was associated with reduced antibody levels,” Mr. Tong.
“And at 13 months post-infection, an elevated BMI was associated with both reduced antibody activity and a reduced percentage of the relevant B cells, a type of cell that helps build these COVID-fighting antibodies.”
At six months following the second COVID-19 immunization, an elevated BMI did not affect antibody response.
Associate Professor Kirsty Short said the findings should impact health policy.
“If infection is associated with an increased risk of severe disease and an impaired immune response for the overweight, this group has a potentially increased risk of reinfection,” stated Dr. Short.
“It makes it more important than ever for this group to ensure they’re vaccinated.”
Dr. Short said this evidence questions booster and lockdown strategies from a public health perspective.
“We’d suggest that more personalized recommendations are needed for overweight people, both for ongoing COVID-19 management and future pandemics,” stated.
“Finally, the data provides an added impetus to improve SARS-CoV-2 vaccination in low-income countries, where there’s a high percentage of people who are overweight and are dependent on infection-induced immunity.”
more recommended stories
Statins and Depression: No Added Benefit
What Are Statins Used For? Statins.
Azithromycin Resistance Rises After Mass Treatment
Mass drug administration (MDA) of azithromycin.
Generative AI in Health Campaigns: A Game-Changer
Mass media campaigns have long been.
Molecular Stress in Aging Neurons Explained
As the population ages, scientists are.
Higher BMI and Hypothyroidism Risk Study
A major longitudinal study from Canada.
Therapeutic Plasma Exchange Reduces Biological Age
Therapeutic plasma exchange (TPE), especially when.
Childhood Cancer Diagnosis Delays Persist
Delays in childhood cancer diagnosis remain.
Hypothalamic Changes in Eating Disorders Explained
Groundbreaking MRI scans reveal microstructural hypothalamic.
Rapid Blood Test for Rare Diseases Revolutionizes Pediatric Diagnosis
A groundbreaking blood test developed by.
Blood Markers for Teen Depression: A Breakthrough in Early Detection
Mental health professionals and researchers have.
Leave a Comment